Astrana Health, Inc. $ASTH is 325 Capital LLC’s 4th Largest Position

325 Capital LLC lifted its position in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 34.6% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,193,953 shares of the company’s stock after purchasing an additional 307,037 shares during the quarter. Astrana Health comprises 10.3% of 325 Capital LLC’s investment portfolio, making the stock its 4th biggest holding. 325 Capital LLC owned approximately 2.12% of Astrana Health worth $33,849,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Covestor Ltd raised its holdings in Astrana Health by 210.6% in the third quarter. Covestor Ltd now owns 3,233 shares of the company’s stock worth $92,000 after purchasing an additional 2,192 shares in the last quarter. Tower Research Capital LLC TRC increased its stake in shares of Astrana Health by 323.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after acquiring an additional 3,517 shares in the last quarter. State of Wyoming bought a new position in shares of Astrana Health in the 2nd quarter worth about $132,000. Citizens Financial Group Inc. RI purchased a new position in Astrana Health during the 3rd quarter valued at about $204,000. Finally, WINTON GROUP Ltd purchased a new position in Astrana Health during the 2nd quarter valued at about $233,000. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Stock Up 4.3%

Shares of Astrana Health stock opened at $24.26 on Friday. The company has a debt-to-equity ratio of 1.25, a quick ratio of 1.40 and a current ratio of 1.40. The stock has a market capitalization of $1.37 billion, a PE ratio of 52.74 and a beta of 0.91. Astrana Health, Inc. has a 52-week low of $18.08 and a 52-week high of $34.80. The company has a 50-day simple moving average of $23.46 and a two-hundred day simple moving average of $25.96.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Monday, March 2nd. The company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.39. The firm had revenue of $950.53 million for the quarter, compared to analysts’ expectations of $930.46 million. Astrana Health had a net margin of 0.71% and a return on equity of 5.59%. The business’s revenue for the quarter was up 42.9% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.15) earnings per share. On average, analysts anticipate that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on ASTH shares. Needham & Company LLC started coverage on shares of Astrana Health in a report on Friday, December 12th. They issued a “buy” rating and a $28.00 price objective on the stock. Zacks Research upgraded shares of Astrana Health from a “strong sell” rating to a “hold” rating in a report on Wednesday. BTIG Research dropped their price target on Astrana Health from $45.00 to $40.00 and set a “buy” rating on the stock in a research report on Monday, February 2nd. Weiss Ratings restated a “sell (d+)” rating on shares of Astrana Health in a research note on Monday, December 29th. Finally, Jefferies Financial Group reaffirmed a “buy” rating on shares of Astrana Health in a research report on Tuesday, November 25th. Five investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $34.00.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.